141
Views
13
CrossRef citations to date
0
Altmetric
Review

The fumaric acid ester BG-12: a new option in MS therapy

, , &
Pages 951-958 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bifeng Gao, An Doan & Brooks M Hybertson. (2014) The clinical potential of influencing Nrf2 signaling in degenerative and immunological disorders. Clinical Pharmacology: Advances and Applications 6, pages 19-34.
Read now

Articles from other publishers (12)

Dmitry M. Hushpulian, Navneet Ammal Kaidery, Debashis Dutta, Sudarshana M. Sharma, Irina Gazaryan & Bobby Thomas. (2023) Emerging small molecule inhibitors of Bach1 as therapeutic agents: Rationale, recent advances, and future perspectives. BioEssays.
Crossref
Mahmood Ahmad Khan, Gulam Rabbani, Juhi Aggarawal & Rafat Sultana Ahmed. (2023) Divulging the Intricacies of Crosstalk Between NF-kB and Nrf-2/Keap1 Pathway in the Treatment of Arthritis by Dimethyl Fumarate. Applied Biochemistry and Biotechnology.
Crossref
Laura Bierhansl, Hans-Peter Hartung, Orhan Aktas, Tobias Ruck, Michael Roden & Sven G. Meuth. (2022) Thinking outside the box: non-canonical targets in multiple sclerosis. Nature Reviews Drug Discovery 21:8, pages 578-600.
Crossref
Houman Kahroba, Bahman Ramezani, Hamid Maadi, Mohammad Reza Sadeghi, Hajar Jaberie & Fatemeh Ramezani. (2021) The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease. Ageing Research Reviews 65, pages 101211.
Crossref
Gerardo G. Piroli, Allison M. Manuel, Tulsi Patel, Michael D. Walla, Liang Shi, Scott A. Lanci, Jingtian Wang, Ashley Galloway, Pavel I. Ortinski, Deanna S. Smith & Norma Frizzell. (2019) Identification of Novel Protein Targets of Dimethyl Fumarate Modification in Neurons and Astrocytes Reveals Actions Independent of Nrf2 Stabilization. Molecular & Cellular Proteomics 18:3, pages 504-519.
Crossref
Ranran Han, Jinting Xiao, Hui Zhai & Junwei Hao. (2016) Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages. Journal of Neuroinflammation 13:1.
Crossref
Itzy E. Morales Pantoja, Che-lin Hu, Nora I. Perrone-Bizzozero, Jianzheng Zheng & Oscar A. Bizzozero. (2016) Nrf2-dysregulation correlates with reduced synthesis and low glutathione levels in experimental autoimmune encephalomyelitis. Journal of Neurochemistry 139:4, pages 640-650.
Crossref
Izaskun Buendia, Elisa Navarro, Patrycja Michalska, Isabel Gameiro, Javier Egea, Sheila Abril, Alicia López, Laura González-Lafuente, Manuela G López & Rafael León. (2015) New melatonin–cinnamate hybrids as multi-target drugs for neurodegenerative diseases: Nrf2-induction, antioxidant effect and neuroprotection. Future Medicinal Chemistry 7:15, pages 1961-1969.
Crossref
Qin Wang, Sergei Chuikov, Sophina Taitano, Qi Wu, Arjun Rastogi, Samuel Tuck, Joseph Corey, Steven Lundy & Yang Mao-Draayer. (2015) Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway. International Journal of Molecular Sciences 16:12, pages 13885-13907.
Crossref
Ian M. Copple, Luke M. Shelton, Joanne Walsh, Denise V. Kratschmar, Adam Lister, Alex Odermatt, Christopher E. Goldring, Albena T. Dinkova-Kostova, Tadashi Honda & B. Kevin Park. (2014) Chemical Tuning Enhances Both Potency Toward Nrf2 and In Vitro Therapeutic Index of Triterpenoids. Toxicological Sciences 140:2, pages 462-469.
Crossref
Michela Rosini, Elena Simoni, Andrea Milelli, Anna Minarini & Carlo Melchiorre. (2013) Oxidative Stress in Alzheimer’s Disease: Are We Connecting the Dots?. Journal of Medicinal Chemistry 57:7, pages 2821-2831.
Crossref
Anja Förster, Liane M. Preussner, Jens M. Seeger, Anja Rabenhorst, Hamid Kashkar, Ulrich Mrowietz & Karin Hartmann. (2013) Dimethylfumarate induces apoptosis in human mast cells. Experimental Dermatology 22:11, pages 719-724.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.